Why I’d dump growth stock Fevertree Drinks plc today

Fevertree Drinks plc (LON: FEVR) now appears to be overvalued.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Fevertree Drinks plc (LSE: FEVR) has experienced a stunning share price rise. The developer and supplier of premium mixer drinks has recorded a capital gain of 90% in 2017, which takes its gain since the November 2014 IPO to almost 1,200%.

Clearly, it has been an exceptional period for investors in the stock, and it may feel as though the company’s valuation will keep rising in perpetuity. However, that is unlikely to be the case. It now has a valuation which means it may be worth selling, rather than buying, at the present time.

Growth potential

Of course, Fevertree has a dominant position within its key markets. It is viewed by many consumers as selling the best mixers in the world. This strength of customer loyalty means that its sales growth is likely to remain robust over the medium term, since consumers are likely to stick with their favourite brand of tonic water or ginger ale, for example.

Strong customer loyalty may also mean that the company has a high degree of pricing power. This may allow it to improve on its current margins, thereby helping profit growth to exceed sales growth over the medium term. Certainly, there is a danger that consumer tastes will change and certain types of alcoholic beverages will come in and out of fashion. However, with tonic water, ginger ale and lemonade being highly adaptable mixers, Fevertree is likely to offer resilient sales numbers over the long run.

High valuation

While it has a sound business model and could perform well as a business, the market seems to have fully priced-in its future growth potential. It is expected to report a rise in its bottom line of 16% in the current year, followed by further growth of 12% next year. However, it trades on a price-to-earnings (P/E) ratio of 91. This means it has a price-to-earnings growth (PEG) ratio of 6.5 at the present time. Even for a business with a sound outlook, such a high valuation is incredibly difficult to justify.

Another ‘sell’

Another stock which may be worth selling rather than buying right now is global engineering and strategic, technical and environmental consultancy business Ricardo (LSE: RCDO). It reported the acquisition of US-based full-service engineering firm Control Point on Wednesday. The purchase is likely to be central to the growth of Ricardo’s defence business and will significantly expand the range of opportunities which can be pursued within the US defence sector.

While positive for the company’s outlook, it continues to lack investment appeal given its current valuation. Ricardo trades on a P/E ratio of 13.8, and yet is expected to increase its bottom line by just 5% next year. This means it has a PEG ratio approaching three, which suggests there may be better opportunities available elsewhere. Certainly, it is making progress as a business, but from an investment perspective it lacks a sufficiently wide margin of safety to merit purchase.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »